Latest News

Background – Genomic classifiers (GC) have been shown to improve risk stratification post prostatectomy. However, their clinical benefit has not been prospectively demonstrated. We sought to determine the impact of GC testing on postoperative management in men with prostate cancer post prostatectomy. Methods – Two prospective registries of prostate cancer patients treated between 2014 and […]

I have previously discussed the use of antibody-drug conjugates for selective tumor cell intensification of urothelial carcinoma therapy in a Urotoday Clinical Trials Portal article.1 Similarly, I’ve also focused on enfortumab vedotin before, and enfortumab vedotin is now FDA approved on the accelerated pathway for patients with locally advanced or metastatic urothelial carcinoma in the post-platinum […]

(UroToday.com) The 2021 European Association of Urology (EAU) Section of Oncological Urology (ESOU) Virtual Annual Meeting’s “Must Read Papers in Urologic Oncology in 2020” included a comprehensive summary of important papers in the urothelial literature by Dr. Thomas Seisen.

(UroToday.com) The final session at the 2021 European Association of Urology (EAU) Section of Oncological Urology (ESOU) Virtual Annual Meeting included a “must-read papers of 2020” session, with Dr. Riccardo Campi presenting the key papers in renal cell carcinoma (RCC). Dr. Campi took an exhaustive approach to assess renal cancer studies published in 2020, searching 17 […]

(UroToday.com) The third renal cancer session at the 2021 European Association of Urology (EAU) Section of Oncological Urology (ESOU) Virtual Annual Meeting focused on the management of patients with advanced and metastatic disease. In this session, Dr. Holger Moch presented on the histological classification and immunophenotyping of renal tumors.

(UroToday.com) The third renal cancer session at the 2021 European Association of Urology (EAU) Section of Oncological Urology (ESOU) Virtual Annual Meeting focused on the management of patients with advanced and metastatic disease. In this session, Dr. Axel Bex provided his perspective on the role of cytoreductive nephrectomy today, including both indications and rationale.

There is increasing enthusiasm for the value of mini PCNL for pediatric stone clearance. In developing countries, it is important to arrange a single stage treatment as a significant proportion of patients do not comply with repeated treatments, such as SWL.

To compare intrapelvic pressure (IPP) levels achieved during f-URS, mini-PCNL, standard PCNL, and endoscopic combined intrarenal surgery in a kidney model. A silicone model simulating the complete urinary tract was used for all the experiments.

The prostatic urethral lift procedure is a minimally invasive treatment option for lower urinary tract symptoms due to benign prostatic hyperplasia, with reported benefit of less adverse effects than traditional treatments.

In clinical trials, few investigations have been conducted to determine the mechanism involved in teriflunomide-associated kidney stone formation. We report the first case of recurrent teriflunomide-induced uric acid urolithiasis.